Characterization of Dosage Levels for In Ovo Administration of Innate Immune Stimulants for Prevention of Yolk Sac Infection in Chicks.

CpG chickens innate immune stimulants poly I:C yolk sac infection

Journal

Veterinary sciences
ISSN: 2306-7381
Titre abrégé: Vet Sci
Pays: Switzerland
ID NLM: 101680127

Informations de publication

Date de publication:
22 Apr 2022
Historique:
received: 10 03 2022
revised: 16 04 2022
accepted: 21 04 2022
entrez: 27 5 2022
pubmed: 28 5 2022
medline: 28 5 2022
Statut: epublish

Résumé

Innate immune stimulants, especially toll-like receptor (TLR) ligands and agonists, are the main players in the initiation of innate immunity and have been widely studied as alternatives to antibiotics to control infection. In the present study, we characterized the dosage levels of various innate immune stimulants, including unmethylated cytosine-phosphate-guanosine dinucleotide -containing oligodeoxynucleotides (CpG ODN), polyinosinic-polycytidylic acid (poly I:C), cyclic polyphosphazene 75B (CPZ75B), avian beta-defensin 2 (ABD2), and combinations of these reagents given in ovo. Data derived from a series of animal experiments demonstrated that the in ovo administration of 10-50 µg CpG ODN/embryo (on embryonic day 18) is an effective formulation for control of yolk sac infection (YSI) due to avian pathogenic

Identifiants

pubmed: 35622731
pii: vetsci9050203
doi: 10.3390/vetsci9050203
pmc: PMC9142911
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Chicken Farmers of Saskatchewan (SCIDF)
ID : 421141
Organisme : Canadian Poultry Research Council (CPRC)/Agri-Agrifood Canada (AAFC)
ID : 421319

Références

J Infect Dis. 2014 Feb 1;209(3):457-67
pubmed: 24014881
Avian Pathol. 2010 Oct;39(5):309-24
pubmed: 20954007
Microorganisms. 2020 Jan 21;8(2):
pubmed: 31973199
Sci Rep. 2019 Jun 3;9(1):8197
pubmed: 31160675
J Infect Dis. 2004 Nov 15;190(10):1841-9
pubmed: 15499542
Clin Microbiol Infect. 2011 Jun;17(6):873-80
pubmed: 21463397
J Immunol. 1998 Sep 1;161(5):2428-34
pubmed: 9725240
Front Immunol. 2020 Jun 12;11:1209
pubmed: 32595649
Immunol Cell Biol. 2011 Aug;89(6):663-9
pubmed: 21339766
Front Immunol. 2020 Mar 11;11:432
pubmed: 32218789
Anim Health Res Rev. 2017 Jun;18(1):26-45
pubmed: 28485263
J Immunol. 2004 Dec 15;173(12):7548-55
pubmed: 15585882
J Clin Invest. 2007 May;117(5):1184-94
pubmed: 17476348
Environ Health Perspect. 2007 Feb;115(2):313-6
pubmed: 17384785
Dev Comp Immunol. 2008;32(4):435-44
pubmed: 17870162
Ann N Y Acad Sci. 2008 Nov;1143:1-20
pubmed: 19076341
Sci Rep. 2020 Mar 24;10(1):5343
pubmed: 32210244
Avian Dis. 2015 Dec;59(4):518-24
pubmed: 26629626
Poult Sci. 2015 Aug;94(8):1791-801
pubmed: 26047674
Front Microbiol. 2019 Nov 14;10:2632
pubmed: 31803163
Anim Health Res Rev. 2013 Jun;14(1):78-87
pubmed: 23702321
Viral Immunol. 2014 May;27(4):167-73
pubmed: 24797893
Avian Pathol. 2014;43(1):78-81
pubmed: 24320598
CMAJ. 2009 Jul 7;181(1-2):21-4
pubmed: 19581614
Cancer Treat Rev. 2018 Feb;63:40-47
pubmed: 29207310
Avian Dis. 2009 Jun;53(2):261-7
pubmed: 19630234
Vaccines (Basel). 2022 Apr 14;10(4):
pubmed: 35455365
Antiviral Res. 2017 Nov;147:1-10
pubmed: 28465147
PLoS One. 2017 Jan 30;12(1):e0170681
pubmed: 28135294
Infect Immun. 2002 Jan;70(1):147-52
pubmed: 11748176
Vet Res. 2011 Feb 02;42:19
pubmed: 21314903
Animal. 2017 Jan;11(1):1-3
pubmed: 27549404
Poult Sci. 2021 Mar;100(3):100934
pubmed: 33652543
Infect Immun. 2003 Feb;71(2):857-63
pubmed: 12540567
Poult Sci. 2019 Apr 1;98(4):1791-1804
pubmed: 30544256
Genet Sel Evol. 2010 Apr 29;42:11
pubmed: 20429884
Avian Dis. 2018 Sep;62(3):316-321
pubmed: 30339510
Antimicrob Resist Infect Control. 2015 Apr 28;4:17
pubmed: 25922664
Can J Vet Res. 1993 Jul;57(3):146-51
pubmed: 8358674
Dev Comp Immunol. 2012 Apr;36(4):756-60
pubmed: 22120532
Sci Rep. 2018 Nov 6;8(1):16370
pubmed: 30401976
Dev Comp Immunol. 2008;32(10):1231-41
pubmed: 18514862
J Infect Dis. 2021 Jul 15;224(2):332-344
pubmed: 33606878
Avian Dis. 2004 Dec;48(4):813-22
pubmed: 15666862
Antibiotics (Basel). 2020 Dec 17;9(12):
pubmed: 33348801
Proc Natl Acad Sci U S A. 2015 May 5;112(18):5649-54
pubmed: 25792457
Infect Immun. 2005 May;73(5):3044-52
pubmed: 15845512
Proc Natl Acad Sci U S A. 2008 May 27;105(21):7528-33
pubmed: 18490660
Mol Immunol. 2007 May;44(12):3234-42
pubmed: 17339052
Lancet. 2011 Jul 23;378(9788):369-71
pubmed: 21477855
J Immunol. 2000 Dec 15;165(12):7096-101
pubmed: 11120839
Emerg Infect Dis. 2016 Apr;22(4):634-40
pubmed: 26982890

Auteurs

Mishal Sarfraz (M)

Vaccine and Infectious Disease Organization (VIDO), University of Saskatchewan, Saskatoon, SK S7N 5E3, Canada.

Thuy Thi Thu Nguyen (TTT)

Vaccine and Infectious Disease Organization (VIDO), University of Saskatchewan, Saskatoon, SK S7N 5E3, Canada.

Colette Wheler (C)

Vaccine and Infectious Disease Organization (VIDO), University of Saskatchewan, Saskatoon, SK S7N 5E3, Canada.

Wolfgang Köster (W)

Vaccine and Infectious Disease Organization (VIDO), University of Saskatchewan, Saskatoon, SK S7N 5E3, Canada.

Volker Gerdts (V)

Vaccine and Infectious Disease Organization (VIDO), University of Saskatchewan, Saskatoon, SK S7N 5E3, Canada.

Arshud Dar (A)

Vaccine and Infectious Disease Organization (VIDO), University of Saskatchewan, Saskatoon, SK S7N 5E3, Canada.

Classifications MeSH